This research provided empirical evidence that the use of fair value principle for biological assets provides significant different valuations of assets and revenues with respect to historic cost, but does neither disclose significant differences in profits, nor
increase volatility, nor bring about different profitability and accounting manipulation. Provided that historic cost is a complex valuation method for biological assets, it seems that fair value is an interesting tool for the predominant small holdings in the
agricultural sector in the European Union.